Supplement for FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis
收藏doi.org2025-03-27 收录
下载链接：
http://doi.org/10.17632/23tcsdt2hc.1
下载链接
链接失效反馈官方服务：
资源简介：
Supplemental material in support of the article "FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis"
支持文章《FRONTIER-2：口服JNJ-77242113用于治疗中度至重度斑块状银屑病的2b期、长期扩展、剂量范围研究》的补充材料
提供机构：
doi.org
